Exane Derivatives Canopy Growth Corp Transaction History

Exane Derivatives

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$2.85 - $7.77 $2,077 - $5,664	-729 Closed	0 $0
Q1 2022 Apr 22, 2022	SELL	$5.7 - $9.3 $507,300 - $827,700	-89,000 Reduced 99.19%	729 $5,000
Q4 2021 Jan 28, 2022	BUY	$8.73 - $15.27 $776,970 - $1.36 Million	89,000 Added 12208.5%	89,729 $783,000
Q1 2021 Apr 30, 2021	SELL	$26.12 - $52.17 $4,858 - $9,703	-186 Reduced 20.33%	729 $23,000
Q4 2020 Jan 27, 2021	SELL	$14.05 - $29.0 $86,997 - $179,568	-6,192 Reduced 87.13%	915 $22,000
Q2 2020 Jul 10, 2020	BUY	$13.25 - $21.72 $80,228 - $131,514	6,055 Added 575.57%	7,107 $114,000
Q1 2020 Apr 17, 2020	SELL	$9.73 - $24.9 $651,306 - $1.67 Million	-66,938 Reduced 98.45%	1,052 $15,000
Q4 2019 Jan 22, 2020	BUY	$14.22 - $23.38 $403,506 - $663,430	28,376 Added 71.63%	67,990 $1.43 Million
Q3 2019 Oct 15, 2019	BUY	$22.93 - $41.06 $547,316 - $980,061	23,869 Added 151.6%	39,614 $908,000
Q2 2019 Jul 12, 2019	BUY	$38.73 - $52.03 $94,423 - $126,849	2,438 Added 18.32%	15,745 $0
Q1 2019 Apr 24, 2019	BUY	$28.11 - $50.77 $374,059 - $675,596	13,307 New	13,307 $0
Q4 2018 Jan 31, 2019	SELL	$26.22 - $56.89 $60,306 - $130,847	-2,300 Closed	0 $0
Q3 2018 Oct 24, 2018	BUY	$24.31 - $52.74 $55,913 - $121,302	2,300 New	2,300 $0

8.28M

400

Ticker CGC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 480,284,000
Market Cap $720M
Description
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include d...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.